Myriad Genetics director awarded 59,701 RSUs
Davis Mark Steven reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Davis Mark Steven reported acquisition or exercise transactions in this Form 4 filing.
Myriad Genetics director Mark Steven Davis received a grant of 59,701 restricted stock units (RSUs) of common stock. The award was granted under the company’s 2026 Employee, Director and Consultant Equity Incentive Plan and carries no purchase price.
Each RSU represents a right to receive one Myriad Genetics common share and will vest upon the earlier of the first anniversary of the grant date or the next annual meeting of stockholders following the grant. After this grant, Davis directly holds 106,665 shares of common stock, reflecting his updated ownership position.
Insider Trade Summary
Grant/Award: 59,701 shares
Grant/Award
1 txn
Insider
Davis Mark Steven
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 59,701 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 106,665 shares (Direct)
Footnotes (1)
- F1. Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant.
Key Figures
RSU grant size: 59,701 RSUs
Total shares after grant: 106,665 shares
Grant price per share: $0.00 per share
3 metrics
RSU grant size
59,701 RSUs
Restricted stock units granted to Mark Steven Davis on 2026-06-04
Total shares after grant
106,665 shares
Direct common stock holdings following the reported transaction
Grant price per share
$0.00 per share
RSUs granted at no purchase price as equity compensation
Key Terms
restricted stock units, Equity Incentive Plan, vests
3 terms
restricted stock units financial
"Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Equity Incentive Plan financial
"granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.
vests financial
"and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Myriad Genetics (MYGN) director Mark Steven Davis report on this Form 4?
Director Mark Steven Davis reported receiving 59,701 restricted stock units of Myriad Genetics common stock as a grant. The award was made under the company’s 2026 Employee, Director and Consultant Equity Incentive Plan as part of his compensation, rather than an open-market stock purchase.
What are the vesting terms for the 59,701 restricted stock units granted by Myriad Genetics (MYGN)?
The 59,701 restricted stock units vest upon the earlier of the first anniversary of the grant date or the next annual meeting of stockholders following the grant. Each vested RSU entitles Mark Steven Davis to receive one share of Myriad Genetics common stock when the vesting condition is satisfied.
Under which plan were the new Myriad Genetics (MYGN) restricted stock units granted to Mark Steven Davis?
The restricted stock units were granted under Myriad Genetics’ 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. This plan provides equity-based compensation, and each of the 59,701 RSUs represents a contingent right to receive one share of the company’s common stock upon vesting.
AI-generated analysis. How Rhea-AI works. Not financial advice.
